Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Forster

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET)Siow Ming Lee, Mary Falzon, Fiona Blackhall, et al.
The Lancet. Oncology|July 2, 2013
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trialShahneen K Sandhu, William R Schelman, George Wilding, et al.
Elife|December 23, 2022
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model developmentPaul R Barber, Rami Mustapha, Fabian Flores-Borja, et al.
Nature|September 5, 2020
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
Nature|July 17, 2020
The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
Acta Neuropathologica|August 11, 2018
Correction to: DNA methylation-based reclassification of olfactory neuroblastomaDavid Capper, Nils W Engel, Damian Stichel, et al.
Acta Neuropathologica|May 7, 2018
DNA methylation-based reclassification of olfactory neuroblastomaDavid Capper, Nils W Engel, Damian Stichel, et al.
Science (New York, N.Y.)|October 11, 2014
Spatial and temporal diversity in genomic instability processes defines lung cancer evolutionElza C de Bruin, Nicholas McGranahan, Richard Mitter, et al.
Nature Communications|November 28, 2022
DNA methylation-based classification of sinonasal tumorsPhilipp Jurmeister, Stefanie Glöß, Renée Roller, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET)Siow Ming Lee, Mary Falzon, Fiona Blackhall, et al.
The Lancet. Oncology|July 2, 2013
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trialShahneen K Sandhu, William R Schelman, George Wilding, et al.
Elife|December 23, 2022
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model developmentPaul R Barber, Rami Mustapha, Fabian Flores-Borja, et al.
Nature|September 5, 2020
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
Nature|July 17, 2020
The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
Acta Neuropathologica|August 11, 2018
Correction to: DNA methylation-based reclassification of olfactory neuroblastomaDavid Capper, Nils W Engel, Damian Stichel, et al.
Acta Neuropathologica|May 7, 2018
DNA methylation-based reclassification of olfactory neuroblastomaDavid Capper, Nils W Engel, Damian Stichel, et al.
Science (New York, N.Y.)|October 11, 2014
Spatial and temporal diversity in genomic instability processes defines lung cancer evolutionElza C de Bruin, Nicholas McGranahan, Richard Mitter, et al.
Nature Communications|November 28, 2022
DNA methylation-based classification of sinonasal tumorsPhilipp Jurmeister, Stefanie Glöß, Renée Roller, et al.
Plos Biology|July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyMariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Pageof 9